Global DPT Series Vaccine Supply, Demand and Key Producers, 2026-2032
The global DPT Series Vaccine market size is expected to reach $ 6737 million by 2032, rising at a market growth of 1.5% CAGR during the forecast period (2026-2032).
The DTP vaccine is a combination vaccine used to prevent three serious infectious diseases: pertussis, diphtheria, and tetanus. It is typically an important component of basic immunization programs for infants and young children. This vaccine is formulated by combining pertussis antigen (whole-cell or acellular), diphtheria toxoid, and tetanus toxoid, inducing the production of specific antibodies in the body to establish immune protection. Depending on the pertussis component, it can be divided into whole-cell (DTwP) and acellular (DTaP) formulations; most countries currently use the acellular formulation to reduce the risk of adverse reactions. The DTP vaccine is usually an adsorbed formulation containing aluminum salt adjuvants to enhance its immunogenicity and is one of the core vaccines in global childhood immunization programs. The global annual demand is approximately 300-400 million doses.
The DPT vaccine (Diphtheria, Pertussis, Tetanus) is a combined vaccine used to prevent three serious infectious diseases: pertussis, diphtheria, and tetanus. It is one of the core vaccines in the global infant immunization program. Depending on the pertussis component, DPT vaccines can be divided into whole-cell (DTwP) and acellular (DTaP) vaccines. Acellular vaccines, due to their lower adverse reactions, have become the mainstream product in most developed countries and emerging markets. As a high-coverage vaccine in immunization programs, the DPT vaccine market is characterized by stable and relatively inelastic demand, while continuously evolving driven by product structure upgrades and the trend towards multivalent vaccines.
In recent years, the global vaccine market has maintained steady growth, with overall childhood immunization program coverage remaining at a high level, providing a long-term stable foundation for demand for DPT vaccines. With the continuous improvement of public health systems in various countries and the increase in immunization coverage in emerging economies, the demand for DPT vaccines continues to be released. At the same time, developed country markets are gradually upgrading from traditional trivalent vaccines to quadrivalent, pentavalent, and hexavalent vaccines, driving up the value of single-dose products. The trend towards multivalent vaccines has become one of the important drivers of market growth.
From a product structure perspective, whole-cell DPT vaccines remain widely used in some developing countries due to their lower cost and stronger immunogenicity. Acellular vaccines dominate in Europe, the US, and parts of the Asia-Pacific region, gaining market favor due to their superior safety profile. Furthermore, demand for reduced-dose booster vaccines (Tdap) for adolescents and adults is gradually increasing, bringing new growth points to the market. Overall, the product structure is shifting from basic immunization to booster immunization and multivalent vaccines.
In terms of industry landscape, the global DPT vaccine market is highly concentrated. Large international vaccine companies possess technological and brand advantages in the high-end acellular and multivalent vaccine sectors, while companies in some emerging markets are competitive in cost control and local supply. With rising vaccine quality standards and stricter regulations, industry entry barriers continue to increase, making R&D capabilities and production consistency core competitive factors for companies.
Looking ahead, the global DPT vaccine market will be driven by three main factors: first, the continued advancement and increased coverage of immunization programs in various countries; second, the increased product value brought about by upgrades to multivalent vaccines; and third, the increased demand resulting from the expansion of the booster immunization population. The overall market growth pace is relatively stable, with structural upgrades becoming the main source of growth.
This report studies the global DPT Series Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for DPT Series Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of DPT Series Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global DPT Series Vaccine total production and demand, 2021-2032, (K Dose)
Global DPT Series Vaccine total production value, 2021-2032, (USD Million)
Global DPT Series Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global DPT Series Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: DPT Series Vaccine domestic production, consumption, key domestic manufacturers and share
Global DPT Series Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global DPT Series Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global DPT Series Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global DPT Series Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, AJ Vaccines, Panacea Biotec, Sino Biopharm, Kangtai Biological Products, Walvax Biotechnology, Serum Institute of India, Bharat Biotech, Boryung Biopharama, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World DPT Series Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global DPT Series Vaccine Market, By Region:
1. How big is the global DPT Series Vaccine market?
2. What is the demand of the global DPT Series Vaccine market?
3. What is the year over year growth of the global DPT Series Vaccine market?
4. What is the production and production value of the global DPT Series Vaccine market?
5. Who are the key producers in the global DPT Series Vaccine market?
6. What are the growth factors driving the market demand?
The DTP vaccine is a combination vaccine used to prevent three serious infectious diseases: pertussis, diphtheria, and tetanus. It is typically an important component of basic immunization programs for infants and young children. This vaccine is formulated by combining pertussis antigen (whole-cell or acellular), diphtheria toxoid, and tetanus toxoid, inducing the production of specific antibodies in the body to establish immune protection. Depending on the pertussis component, it can be divided into whole-cell (DTwP) and acellular (DTaP) formulations; most countries currently use the acellular formulation to reduce the risk of adverse reactions. The DTP vaccine is usually an adsorbed formulation containing aluminum salt adjuvants to enhance its immunogenicity and is one of the core vaccines in global childhood immunization programs. The global annual demand is approximately 300-400 million doses.
The DPT vaccine (Diphtheria, Pertussis, Tetanus) is a combined vaccine used to prevent three serious infectious diseases: pertussis, diphtheria, and tetanus. It is one of the core vaccines in the global infant immunization program. Depending on the pertussis component, DPT vaccines can be divided into whole-cell (DTwP) and acellular (DTaP) vaccines. Acellular vaccines, due to their lower adverse reactions, have become the mainstream product in most developed countries and emerging markets. As a high-coverage vaccine in immunization programs, the DPT vaccine market is characterized by stable and relatively inelastic demand, while continuously evolving driven by product structure upgrades and the trend towards multivalent vaccines.
In recent years, the global vaccine market has maintained steady growth, with overall childhood immunization program coverage remaining at a high level, providing a long-term stable foundation for demand for DPT vaccines. With the continuous improvement of public health systems in various countries and the increase in immunization coverage in emerging economies, the demand for DPT vaccines continues to be released. At the same time, developed country markets are gradually upgrading from traditional trivalent vaccines to quadrivalent, pentavalent, and hexavalent vaccines, driving up the value of single-dose products. The trend towards multivalent vaccines has become one of the important drivers of market growth.
From a product structure perspective, whole-cell DPT vaccines remain widely used in some developing countries due to their lower cost and stronger immunogenicity. Acellular vaccines dominate in Europe, the US, and parts of the Asia-Pacific region, gaining market favor due to their superior safety profile. Furthermore, demand for reduced-dose booster vaccines (Tdap) for adolescents and adults is gradually increasing, bringing new growth points to the market. Overall, the product structure is shifting from basic immunization to booster immunization and multivalent vaccines.
In terms of industry landscape, the global DPT vaccine market is highly concentrated. Large international vaccine companies possess technological and brand advantages in the high-end acellular and multivalent vaccine sectors, while companies in some emerging markets are competitive in cost control and local supply. With rising vaccine quality standards and stricter regulations, industry entry barriers continue to increase, making R&D capabilities and production consistency core competitive factors for companies.
Looking ahead, the global DPT vaccine market will be driven by three main factors: first, the continued advancement and increased coverage of immunization programs in various countries; second, the increased product value brought about by upgrades to multivalent vaccines; and third, the increased demand resulting from the expansion of the booster immunization population. The overall market growth pace is relatively stable, with structural upgrades becoming the main source of growth.
This report studies the global DPT Series Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for DPT Series Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of DPT Series Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global DPT Series Vaccine total production and demand, 2021-2032, (K Dose)
Global DPT Series Vaccine total production value, 2021-2032, (USD Million)
Global DPT Series Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global DPT Series Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: DPT Series Vaccine domestic production, consumption, key domestic manufacturers and share
Global DPT Series Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global DPT Series Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global DPT Series Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global DPT Series Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, AJ Vaccines, Panacea Biotec, Sino Biopharm, Kangtai Biological Products, Walvax Biotechnology, Serum Institute of India, Bharat Biotech, Boryung Biopharama, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World DPT Series Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global DPT Series Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Whole-cell DPT Vaccine
- Acellular DPT Vaccine
- Trivalent Vaccine
- Quadrivalent Vaccine
- Pentavalent Vaccine
- Others
- Basic Vaccines
- Booster Vaccines
- Public
- Private
- Sanofi
- GSK
- AJ Vaccines
- Panacea Biotec
- Sino Biopharm
- Kangtai Biological Products
- Walvax Biotechnology
- Serum Institute of India
- Bharat Biotech
- Boryung Biopharama
- Tanabe Pharma
- KM Biologics
1. How big is the global DPT Series Vaccine market?
2. What is the demand of the global DPT Series Vaccine market?
3. What is the year over year growth of the global DPT Series Vaccine market?
4. What is the production and production value of the global DPT Series Vaccine market?
5. Who are the key producers in the global DPT Series Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 DPT Series Vaccine Introduction
1.2 World DPT Series Vaccine Supply & Forecast
1.2.1 World DPT Series Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World DPT Series Vaccine Production (2021-2032)
1.2.3 World DPT Series Vaccine Pricing Trends (2021-2032)
1.3 World DPT Series Vaccine Production by Region (Based on Production Site)
1.3.1 World DPT Series Vaccine Production Value by Region (2021-2032)
1.3.2 World DPT Series Vaccine Production by Region (2021-2032)
1.3.3 World DPT Series Vaccine Average Price by Region (2021-2032)
1.3.4 North America DPT Series Vaccine Production (2021-2032)
1.3.5 Europe DPT Series Vaccine Production (2021-2032)
1.3.6 China DPT Series Vaccine Production (2021-2032)
1.3.7 Japan DPT Series Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 DPT Series Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 DPT Series Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World DPT Series Vaccine Demand (2021-2032)
2.2 World DPT Series Vaccine Consumption by Region
2.2.1 World DPT Series Vaccine Consumption by Region (2021-2026)
2.2.2 World DPT Series Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States DPT Series Vaccine Consumption (2021-2032)
2.4 China DPT Series Vaccine Consumption (2021-2032)
2.5 Europe DPT Series Vaccine Consumption (2021-2032)
2.6 Japan DPT Series Vaccine Consumption (2021-2032)
2.7 South Korea DPT Series Vaccine Consumption (2021-2032)
2.8 ASEAN DPT Series Vaccine Consumption (2021-2032)
2.9 India DPT Series Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World DPT Series Vaccine Production Value by Manufacturer (2021-2026)
3.2 World DPT Series Vaccine Production by Manufacturer (2021-2026)
3.3 World DPT Series Vaccine Average Price by Manufacturer (2021-2026)
3.4 DPT Series Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global DPT Series Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for DPT Series Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for DPT Series Vaccine in 2025
3.6 DPT Series Vaccine Market: Overall Company Footprint Analysis
3.6.1 DPT Series Vaccine Market: Region Footprint
3.6.2 DPT Series Vaccine Market: Company Product Type Footprint
3.6.3 DPT Series Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: DPT Series Vaccine Production Value Comparison
4.1.1 United States VS China: DPT Series Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: DPT Series Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: DPT Series Vaccine Production Comparison
4.2.1 United States VS China: DPT Series Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: DPT Series Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: DPT Series Vaccine Consumption Comparison
4.3.1 United States VS China: DPT Series Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: DPT Series Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based DPT Series Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based DPT Series Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers DPT Series Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers DPT Series Vaccine Production (2021-2026)
4.5 China Based DPT Series Vaccine Manufacturers and Market Share
4.5.1 China Based DPT Series Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers DPT Series Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers DPT Series Vaccine Production (2021-2026)
4.6 Rest of World Based DPT Series Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based DPT Series Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers DPT Series Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers DPT Series Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World DPT Series Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Whole-cell DPT Vaccine
5.2.2 Acellular DPT Vaccine
5.3 Market Segment by Type
5.3.1 World DPT Series Vaccine Production by Type (2021-2032)
5.3.2 World DPT Series Vaccine Production Value by Type (2021-2032)
5.3.3 World DPT Series Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY COMBINATION
6.1 World DPT Series Vaccine Market Size Overview by Combination: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Combination
6.2.1 Trivalent Vaccine
6.2.2 Quadrivalent Vaccine
6.2.3 Pentavalent Vaccine
6.2.4 Others
6.3 Market Segment by Combination
6.3.1 World DPT Series Vaccine Production by Combination (2021-2032)
6.3.2 World DPT Series Vaccine Production Value by Combination (2021-2032)
6.3.3 World DPT Series Vaccine Average Price by Combination (2021-2032)
7 MARKET ANALYSIS BY EFFECT
7.1 World DPT Series Vaccine Market Size Overview by Effect: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Effect
7.2.1 Basic Vaccines
7.2.2 Booster Vaccines
7.3 Market Segment by Effect
7.3.1 World DPT Series Vaccine Production by Effect (2021-2032)
7.3.2 World DPT Series Vaccine Production Value by Effect (2021-2032)
7.3.3 World DPT Series Vaccine Average Price by Effect (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World DPT Series Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public
8.2.2 Private
8.3 Market Segment by Application
8.3.1 World DPT Series Vaccine Production by Application (2021-2032)
8.3.2 World DPT Series Vaccine Production Value by Application (2021-2032)
8.3.3 World DPT Series Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sanofi
9.1.1 Sanofi Details
9.1.2 Sanofi Major Business
9.1.3 Sanofi DPT Series Vaccine Product and Services
9.1.4 Sanofi DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sanofi Recent Developments/Updates
9.1.6 Sanofi Competitive Strengths & Weaknesses
9.2 GSK
9.2.1 GSK Details
9.2.2 GSK Major Business
9.2.3 GSK DPT Series Vaccine Product and Services
9.2.4 GSK DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 GSK Recent Developments/Updates
9.2.6 GSK Competitive Strengths & Weaknesses
9.3 AJ Vaccines
9.3.1 AJ Vaccines Details
9.3.2 AJ Vaccines Major Business
9.3.3 AJ Vaccines DPT Series Vaccine Product and Services
9.3.4 AJ Vaccines DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 AJ Vaccines Recent Developments/Updates
9.3.6 AJ Vaccines Competitive Strengths & Weaknesses
9.4 Panacea Biotec
9.4.1 Panacea Biotec Details
9.4.2 Panacea Biotec Major Business
9.4.3 Panacea Biotec DPT Series Vaccine Product and Services
9.4.4 Panacea Biotec DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Panacea Biotec Recent Developments/Updates
9.4.6 Panacea Biotec Competitive Strengths & Weaknesses
9.5 Sino Biopharm
9.5.1 Sino Biopharm Details
9.5.2 Sino Biopharm Major Business
9.5.3 Sino Biopharm DPT Series Vaccine Product and Services
9.5.4 Sino Biopharm DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Sino Biopharm Recent Developments/Updates
9.5.6 Sino Biopharm Competitive Strengths & Weaknesses
9.6 Kangtai Biological Products
9.6.1 Kangtai Biological Products Details
9.6.2 Kangtai Biological Products Major Business
9.6.3 Kangtai Biological Products DPT Series Vaccine Product and Services
9.6.4 Kangtai Biological Products DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Kangtai Biological Products Recent Developments/Updates
9.6.6 Kangtai Biological Products Competitive Strengths & Weaknesses
9.7 Walvax Biotechnology
9.7.1 Walvax Biotechnology Details
9.7.2 Walvax Biotechnology Major Business
9.7.3 Walvax Biotechnology DPT Series Vaccine Product and Services
9.7.4 Walvax Biotechnology DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Walvax Biotechnology Recent Developments/Updates
9.7.6 Walvax Biotechnology Competitive Strengths & Weaknesses
9.8 Serum Institute of India
9.8.1 Serum Institute of India Details
9.8.2 Serum Institute of India Major Business
9.8.3 Serum Institute of India DPT Series Vaccine Product and Services
9.8.4 Serum Institute of India DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Serum Institute of India Recent Developments/Updates
9.8.6 Serum Institute of India Competitive Strengths & Weaknesses
9.9 Bharat Biotech
9.9.1 Bharat Biotech Details
9.9.2 Bharat Biotech Major Business
9.9.3 Bharat Biotech DPT Series Vaccine Product and Services
9.9.4 Bharat Biotech DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Bharat Biotech Recent Developments/Updates
9.9.6 Bharat Biotech Competitive Strengths & Weaknesses
9.10 Boryung Biopharama
9.10.1 Boryung Biopharama Details
9.10.2 Boryung Biopharama Major Business
9.10.3 Boryung Biopharama DPT Series Vaccine Product and Services
9.10.4 Boryung Biopharama DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Boryung Biopharama Recent Developments/Updates
9.10.6 Boryung Biopharama Competitive Strengths & Weaknesses
9.11 Tanabe Pharma
9.11.1 Tanabe Pharma Details
9.11.2 Tanabe Pharma Major Business
9.11.3 Tanabe Pharma DPT Series Vaccine Product and Services
9.11.4 Tanabe Pharma DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Tanabe Pharma Recent Developments/Updates
9.11.6 Tanabe Pharma Competitive Strengths & Weaknesses
9.12 KM Biologics
9.12.1 KM Biologics Details
9.12.2 KM Biologics Major Business
9.12.3 KM Biologics DPT Series Vaccine Product and Services
9.12.4 KM Biologics DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 KM Biologics Recent Developments/Updates
9.12.6 KM Biologics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 DPT Series Vaccine Industry Chain
10.2 DPT Series Vaccine Upstream Analysis
10.2.1 DPT Series Vaccine Core Raw Materials
10.2.2 Main Manufacturers of DPT Series Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 DPT Series Vaccine Production Mode
10.6 DPT Series Vaccine Procurement Model
10.7 DPT Series Vaccine Industry Sales Model and Sales Channels
10.7.1 DPT Series Vaccine Sales Model
10.7.2 DPT Series Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 DPT Series Vaccine Introduction
1.2 World DPT Series Vaccine Supply & Forecast
1.2.1 World DPT Series Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World DPT Series Vaccine Production (2021-2032)
1.2.3 World DPT Series Vaccine Pricing Trends (2021-2032)
1.3 World DPT Series Vaccine Production by Region (Based on Production Site)
1.3.1 World DPT Series Vaccine Production Value by Region (2021-2032)
1.3.2 World DPT Series Vaccine Production by Region (2021-2032)
1.3.3 World DPT Series Vaccine Average Price by Region (2021-2032)
1.3.4 North America DPT Series Vaccine Production (2021-2032)
1.3.5 Europe DPT Series Vaccine Production (2021-2032)
1.3.6 China DPT Series Vaccine Production (2021-2032)
1.3.7 Japan DPT Series Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 DPT Series Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 DPT Series Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World DPT Series Vaccine Demand (2021-2032)
2.2 World DPT Series Vaccine Consumption by Region
2.2.1 World DPT Series Vaccine Consumption by Region (2021-2026)
2.2.2 World DPT Series Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States DPT Series Vaccine Consumption (2021-2032)
2.4 China DPT Series Vaccine Consumption (2021-2032)
2.5 Europe DPT Series Vaccine Consumption (2021-2032)
2.6 Japan DPT Series Vaccine Consumption (2021-2032)
2.7 South Korea DPT Series Vaccine Consumption (2021-2032)
2.8 ASEAN DPT Series Vaccine Consumption (2021-2032)
2.9 India DPT Series Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World DPT Series Vaccine Production Value by Manufacturer (2021-2026)
3.2 World DPT Series Vaccine Production by Manufacturer (2021-2026)
3.3 World DPT Series Vaccine Average Price by Manufacturer (2021-2026)
3.4 DPT Series Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global DPT Series Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for DPT Series Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for DPT Series Vaccine in 2025
3.6 DPT Series Vaccine Market: Overall Company Footprint Analysis
3.6.1 DPT Series Vaccine Market: Region Footprint
3.6.2 DPT Series Vaccine Market: Company Product Type Footprint
3.6.3 DPT Series Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: DPT Series Vaccine Production Value Comparison
4.1.1 United States VS China: DPT Series Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: DPT Series Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: DPT Series Vaccine Production Comparison
4.2.1 United States VS China: DPT Series Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: DPT Series Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: DPT Series Vaccine Consumption Comparison
4.3.1 United States VS China: DPT Series Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: DPT Series Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based DPT Series Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based DPT Series Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers DPT Series Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers DPT Series Vaccine Production (2021-2026)
4.5 China Based DPT Series Vaccine Manufacturers and Market Share
4.5.1 China Based DPT Series Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers DPT Series Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers DPT Series Vaccine Production (2021-2026)
4.6 Rest of World Based DPT Series Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based DPT Series Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers DPT Series Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers DPT Series Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World DPT Series Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Whole-cell DPT Vaccine
5.2.2 Acellular DPT Vaccine
5.3 Market Segment by Type
5.3.1 World DPT Series Vaccine Production by Type (2021-2032)
5.3.2 World DPT Series Vaccine Production Value by Type (2021-2032)
5.3.3 World DPT Series Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY COMBINATION
6.1 World DPT Series Vaccine Market Size Overview by Combination: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Combination
6.2.1 Trivalent Vaccine
6.2.2 Quadrivalent Vaccine
6.2.3 Pentavalent Vaccine
6.2.4 Others
6.3 Market Segment by Combination
6.3.1 World DPT Series Vaccine Production by Combination (2021-2032)
6.3.2 World DPT Series Vaccine Production Value by Combination (2021-2032)
6.3.3 World DPT Series Vaccine Average Price by Combination (2021-2032)
7 MARKET ANALYSIS BY EFFECT
7.1 World DPT Series Vaccine Market Size Overview by Effect: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Effect
7.2.1 Basic Vaccines
7.2.2 Booster Vaccines
7.3 Market Segment by Effect
7.3.1 World DPT Series Vaccine Production by Effect (2021-2032)
7.3.2 World DPT Series Vaccine Production Value by Effect (2021-2032)
7.3.3 World DPT Series Vaccine Average Price by Effect (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World DPT Series Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public
8.2.2 Private
8.3 Market Segment by Application
8.3.1 World DPT Series Vaccine Production by Application (2021-2032)
8.3.2 World DPT Series Vaccine Production Value by Application (2021-2032)
8.3.3 World DPT Series Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sanofi
9.1.1 Sanofi Details
9.1.2 Sanofi Major Business
9.1.3 Sanofi DPT Series Vaccine Product and Services
9.1.4 Sanofi DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sanofi Recent Developments/Updates
9.1.6 Sanofi Competitive Strengths & Weaknesses
9.2 GSK
9.2.1 GSK Details
9.2.2 GSK Major Business
9.2.3 GSK DPT Series Vaccine Product and Services
9.2.4 GSK DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 GSK Recent Developments/Updates
9.2.6 GSK Competitive Strengths & Weaknesses
9.3 AJ Vaccines
9.3.1 AJ Vaccines Details
9.3.2 AJ Vaccines Major Business
9.3.3 AJ Vaccines DPT Series Vaccine Product and Services
9.3.4 AJ Vaccines DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 AJ Vaccines Recent Developments/Updates
9.3.6 AJ Vaccines Competitive Strengths & Weaknesses
9.4 Panacea Biotec
9.4.1 Panacea Biotec Details
9.4.2 Panacea Biotec Major Business
9.4.3 Panacea Biotec DPT Series Vaccine Product and Services
9.4.4 Panacea Biotec DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Panacea Biotec Recent Developments/Updates
9.4.6 Panacea Biotec Competitive Strengths & Weaknesses
9.5 Sino Biopharm
9.5.1 Sino Biopharm Details
9.5.2 Sino Biopharm Major Business
9.5.3 Sino Biopharm DPT Series Vaccine Product and Services
9.5.4 Sino Biopharm DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Sino Biopharm Recent Developments/Updates
9.5.6 Sino Biopharm Competitive Strengths & Weaknesses
9.6 Kangtai Biological Products
9.6.1 Kangtai Biological Products Details
9.6.2 Kangtai Biological Products Major Business
9.6.3 Kangtai Biological Products DPT Series Vaccine Product and Services
9.6.4 Kangtai Biological Products DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Kangtai Biological Products Recent Developments/Updates
9.6.6 Kangtai Biological Products Competitive Strengths & Weaknesses
9.7 Walvax Biotechnology
9.7.1 Walvax Biotechnology Details
9.7.2 Walvax Biotechnology Major Business
9.7.3 Walvax Biotechnology DPT Series Vaccine Product and Services
9.7.4 Walvax Biotechnology DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Walvax Biotechnology Recent Developments/Updates
9.7.6 Walvax Biotechnology Competitive Strengths & Weaknesses
9.8 Serum Institute of India
9.8.1 Serum Institute of India Details
9.8.2 Serum Institute of India Major Business
9.8.3 Serum Institute of India DPT Series Vaccine Product and Services
9.8.4 Serum Institute of India DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Serum Institute of India Recent Developments/Updates
9.8.6 Serum Institute of India Competitive Strengths & Weaknesses
9.9 Bharat Biotech
9.9.1 Bharat Biotech Details
9.9.2 Bharat Biotech Major Business
9.9.3 Bharat Biotech DPT Series Vaccine Product and Services
9.9.4 Bharat Biotech DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Bharat Biotech Recent Developments/Updates
9.9.6 Bharat Biotech Competitive Strengths & Weaknesses
9.10 Boryung Biopharama
9.10.1 Boryung Biopharama Details
9.10.2 Boryung Biopharama Major Business
9.10.3 Boryung Biopharama DPT Series Vaccine Product and Services
9.10.4 Boryung Biopharama DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Boryung Biopharama Recent Developments/Updates
9.10.6 Boryung Biopharama Competitive Strengths & Weaknesses
9.11 Tanabe Pharma
9.11.1 Tanabe Pharma Details
9.11.2 Tanabe Pharma Major Business
9.11.3 Tanabe Pharma DPT Series Vaccine Product and Services
9.11.4 Tanabe Pharma DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Tanabe Pharma Recent Developments/Updates
9.11.6 Tanabe Pharma Competitive Strengths & Weaknesses
9.12 KM Biologics
9.12.1 KM Biologics Details
9.12.2 KM Biologics Major Business
9.12.3 KM Biologics DPT Series Vaccine Product and Services
9.12.4 KM Biologics DPT Series Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 KM Biologics Recent Developments/Updates
9.12.6 KM Biologics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 DPT Series Vaccine Industry Chain
10.2 DPT Series Vaccine Upstream Analysis
10.2.1 DPT Series Vaccine Core Raw Materials
10.2.2 Main Manufacturers of DPT Series Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 DPT Series Vaccine Production Mode
10.6 DPT Series Vaccine Procurement Model
10.7 DPT Series Vaccine Industry Sales Model and Sales Channels
10.7.1 DPT Series Vaccine Sales Model
10.7.2 DPT Series Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World DPT Series Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World DPT Series Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World DPT Series Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World DPT Series Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World DPT Series Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World DPT Series Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World DPT Series Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World DPT Series Vaccine Production Market Share by Region (2021-2026)
Table 9. World DPT Series Vaccine Production Market Share by Region (2027-2032)
Table 10. World DPT Series Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World DPT Series Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. DPT Series Vaccine Major Market Trends
Table 13. World DPT Series Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World DPT Series Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World DPT Series Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World DPT Series Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key DPT Series Vaccine Producers in 2025
Table 18. World DPT Series Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key DPT Series Vaccine Producers in 2025
Table 20. World DPT Series Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global DPT Series Vaccine Company Evaluation Quadrant
Table 22. World DPT Series Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and DPT Series Vaccine Production Site of Key Manufacturer
Table 24. DPT Series Vaccine Market: Company Product Type Footprint
Table 25. DPT Series Vaccine Market: Company Product Application Footprint
Table 26. DPT Series Vaccine Competitive Factors
Table 27. DPT Series Vaccine New Entrant and Capacity Expansion Plans
Table 28. DPT Series Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China DPT Series Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China DPT Series Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China DPT Series Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based DPT Series Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers DPT Series Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers DPT Series Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers DPT Series Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers DPT Series Vaccine Production Market Share (2021-2026)
Table 37. China Based DPT Series Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers DPT Series Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers DPT Series Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers DPT Series Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers DPT Series Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based DPT Series Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers DPT Series Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers DPT Series Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers DPT Series Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers DPT Series Vaccine Production Market Share (2021-2026)
Table 47. World DPT Series Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World DPT Series Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World DPT Series Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World DPT Series Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World DPT Series Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World DPT Series Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World DPT Series Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World DPT Series Vaccine Production Value by Combination, (USD Million), 2021 & 2025 & 2032
Table 55. World DPT Series Vaccine Production by Combination (2021-2026) & (K Dose)
Table 56. World DPT Series Vaccine Production by Combination (2027-2032) & (K Dose)
Table 57. World DPT Series Vaccine Production Value by Combination (2021-2026) & (USD Million)
Table 58. World DPT Series Vaccine Production Value by Combination (2027-2032) & (USD Million)
Table 59. World DPT Series Vaccine Average Price by Combination (2021-2026) & (US$/Dose)
Table 60. World DPT Series Vaccine Average Price by Combination (2027-2032) & (US$/Dose)
Table 61. World DPT Series Vaccine Production Value by Effect, (USD Million), 2021 & 2025 & 2032
Table 62. World DPT Series Vaccine Production by Effect (2021-2026) & (K Dose)
Table 63. World DPT Series Vaccine Production by Effect (2027-2032) & (K Dose)
Table 64. World DPT Series Vaccine Production Value by Effect (2021-2026) & (USD Million)
Table 65. World DPT Series Vaccine Production Value by Effect (2027-2032) & (USD Million)
Table 66. World DPT Series Vaccine Average Price by Effect (2021-2026) & (US$/Dose)
Table 67. World DPT Series Vaccine Average Price by Effect (2027-2032) & (US$/Dose)
Table 68. World DPT Series Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World DPT Series Vaccine Production by Application (2021-2026) & (K Dose)
Table 70. World DPT Series Vaccine Production by Application (2027-2032) & (K Dose)
Table 71. World DPT Series Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World DPT Series Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World DPT Series Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World DPT Series Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Sanofi Basic Information, Manufacturing Base and Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi DPT Series Vaccine Product and Services
Table 78. Sanofi DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sanofi Recent Developments/Updates
Table 80. Sanofi Competitive Strengths & Weaknesses
Table 81. GSK Basic Information, Manufacturing Base and Competitors
Table 82. GSK Major Business
Table 83. GSK DPT Series Vaccine Product and Services
Table 84. GSK DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. GSK Recent Developments/Updates
Table 86. GSK Competitive Strengths & Weaknesses
Table 87. AJ Vaccines Basic Information, Manufacturing Base and Competitors
Table 88. AJ Vaccines Major Business
Table 89. AJ Vaccines DPT Series Vaccine Product and Services
Table 90. AJ Vaccines DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. AJ Vaccines Recent Developments/Updates
Table 92. AJ Vaccines Competitive Strengths & Weaknesses
Table 93. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 94. Panacea Biotec Major Business
Table 95. Panacea Biotec DPT Series Vaccine Product and Services
Table 96. Panacea Biotec DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Panacea Biotec Recent Developments/Updates
Table 98. Panacea Biotec Competitive Strengths & Weaknesses
Table 99. Sino Biopharm Basic Information, Manufacturing Base and Competitors
Table 100. Sino Biopharm Major Business
Table 101. Sino Biopharm DPT Series Vaccine Product and Services
Table 102. Sino Biopharm DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Sino Biopharm Recent Developments/Updates
Table 104. Sino Biopharm Competitive Strengths & Weaknesses
Table 105. Kangtai Biological Products Basic Information, Manufacturing Base and Competitors
Table 106. Kangtai Biological Products Major Business
Table 107. Kangtai Biological Products DPT Series Vaccine Product and Services
Table 108. Kangtai Biological Products DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Kangtai Biological Products Recent Developments/Updates
Table 110. Kangtai Biological Products Competitive Strengths & Weaknesses
Table 111. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 112. Walvax Biotechnology Major Business
Table 113. Walvax Biotechnology DPT Series Vaccine Product and Services
Table 114. Walvax Biotechnology DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Walvax Biotechnology Recent Developments/Updates
Table 116. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 117. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 118. Serum Institute of India Major Business
Table 119. Serum Institute of India DPT Series Vaccine Product and Services
Table 120. Serum Institute of India DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Serum Institute of India Recent Developments/Updates
Table 122. Serum Institute of India Competitive Strengths & Weaknesses
Table 123. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 124. Bharat Biotech Major Business
Table 125. Bharat Biotech DPT Series Vaccine Product and Services
Table 126. Bharat Biotech DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Bharat Biotech Recent Developments/Updates
Table 128. Bharat Biotech Competitive Strengths & Weaknesses
Table 129. Boryung Biopharama Basic Information, Manufacturing Base and Competitors
Table 130. Boryung Biopharama Major Business
Table 131. Boryung Biopharama DPT Series Vaccine Product and Services
Table 132. Boryung Biopharama DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Boryung Biopharama Recent Developments/Updates
Table 134. Boryung Biopharama Competitive Strengths & Weaknesses
Table 135. Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 136. Tanabe Pharma Major Business
Table 137. Tanabe Pharma DPT Series Vaccine Product and Services
Table 138. Tanabe Pharma DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Tanabe Pharma Recent Developments/Updates
Table 140. Tanabe Pharma Competitive Strengths & Weaknesses
Table 141. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 142. KM Biologics Major Business
Table 143. KM Biologics DPT Series Vaccine Product and Services
Table 144. KM Biologics DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. KM Biologics Recent Developments/Updates
Table 146. KM Biologics Competitive Strengths & Weaknesses
Table 147. Global Key Players of DPT Series Vaccine Upstream (Raw Materials)
Table 148. Global DPT Series Vaccine Typical Customers
Table 149. DPT Series Vaccine Typical Distributors
Table 1. World DPT Series Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World DPT Series Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World DPT Series Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World DPT Series Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World DPT Series Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World DPT Series Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World DPT Series Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World DPT Series Vaccine Production Market Share by Region (2021-2026)
Table 9. World DPT Series Vaccine Production Market Share by Region (2027-2032)
Table 10. World DPT Series Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World DPT Series Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. DPT Series Vaccine Major Market Trends
Table 13. World DPT Series Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World DPT Series Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World DPT Series Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World DPT Series Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key DPT Series Vaccine Producers in 2025
Table 18. World DPT Series Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key DPT Series Vaccine Producers in 2025
Table 20. World DPT Series Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global DPT Series Vaccine Company Evaluation Quadrant
Table 22. World DPT Series Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and DPT Series Vaccine Production Site of Key Manufacturer
Table 24. DPT Series Vaccine Market: Company Product Type Footprint
Table 25. DPT Series Vaccine Market: Company Product Application Footprint
Table 26. DPT Series Vaccine Competitive Factors
Table 27. DPT Series Vaccine New Entrant and Capacity Expansion Plans
Table 28. DPT Series Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China DPT Series Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China DPT Series Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China DPT Series Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based DPT Series Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers DPT Series Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers DPT Series Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers DPT Series Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers DPT Series Vaccine Production Market Share (2021-2026)
Table 37. China Based DPT Series Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers DPT Series Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers DPT Series Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers DPT Series Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers DPT Series Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based DPT Series Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers DPT Series Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers DPT Series Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers DPT Series Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers DPT Series Vaccine Production Market Share (2021-2026)
Table 47. World DPT Series Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World DPT Series Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World DPT Series Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World DPT Series Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World DPT Series Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World DPT Series Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World DPT Series Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World DPT Series Vaccine Production Value by Combination, (USD Million), 2021 & 2025 & 2032
Table 55. World DPT Series Vaccine Production by Combination (2021-2026) & (K Dose)
Table 56. World DPT Series Vaccine Production by Combination (2027-2032) & (K Dose)
Table 57. World DPT Series Vaccine Production Value by Combination (2021-2026) & (USD Million)
Table 58. World DPT Series Vaccine Production Value by Combination (2027-2032) & (USD Million)
Table 59. World DPT Series Vaccine Average Price by Combination (2021-2026) & (US$/Dose)
Table 60. World DPT Series Vaccine Average Price by Combination (2027-2032) & (US$/Dose)
Table 61. World DPT Series Vaccine Production Value by Effect, (USD Million), 2021 & 2025 & 2032
Table 62. World DPT Series Vaccine Production by Effect (2021-2026) & (K Dose)
Table 63. World DPT Series Vaccine Production by Effect (2027-2032) & (K Dose)
Table 64. World DPT Series Vaccine Production Value by Effect (2021-2026) & (USD Million)
Table 65. World DPT Series Vaccine Production Value by Effect (2027-2032) & (USD Million)
Table 66. World DPT Series Vaccine Average Price by Effect (2021-2026) & (US$/Dose)
Table 67. World DPT Series Vaccine Average Price by Effect (2027-2032) & (US$/Dose)
Table 68. World DPT Series Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World DPT Series Vaccine Production by Application (2021-2026) & (K Dose)
Table 70. World DPT Series Vaccine Production by Application (2027-2032) & (K Dose)
Table 71. World DPT Series Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World DPT Series Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World DPT Series Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World DPT Series Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Sanofi Basic Information, Manufacturing Base and Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi DPT Series Vaccine Product and Services
Table 78. Sanofi DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sanofi Recent Developments/Updates
Table 80. Sanofi Competitive Strengths & Weaknesses
Table 81. GSK Basic Information, Manufacturing Base and Competitors
Table 82. GSK Major Business
Table 83. GSK DPT Series Vaccine Product and Services
Table 84. GSK DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. GSK Recent Developments/Updates
Table 86. GSK Competitive Strengths & Weaknesses
Table 87. AJ Vaccines Basic Information, Manufacturing Base and Competitors
Table 88. AJ Vaccines Major Business
Table 89. AJ Vaccines DPT Series Vaccine Product and Services
Table 90. AJ Vaccines DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. AJ Vaccines Recent Developments/Updates
Table 92. AJ Vaccines Competitive Strengths & Weaknesses
Table 93. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 94. Panacea Biotec Major Business
Table 95. Panacea Biotec DPT Series Vaccine Product and Services
Table 96. Panacea Biotec DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Panacea Biotec Recent Developments/Updates
Table 98. Panacea Biotec Competitive Strengths & Weaknesses
Table 99. Sino Biopharm Basic Information, Manufacturing Base and Competitors
Table 100. Sino Biopharm Major Business
Table 101. Sino Biopharm DPT Series Vaccine Product and Services
Table 102. Sino Biopharm DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Sino Biopharm Recent Developments/Updates
Table 104. Sino Biopharm Competitive Strengths & Weaknesses
Table 105. Kangtai Biological Products Basic Information, Manufacturing Base and Competitors
Table 106. Kangtai Biological Products Major Business
Table 107. Kangtai Biological Products DPT Series Vaccine Product and Services
Table 108. Kangtai Biological Products DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Kangtai Biological Products Recent Developments/Updates
Table 110. Kangtai Biological Products Competitive Strengths & Weaknesses
Table 111. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 112. Walvax Biotechnology Major Business
Table 113. Walvax Biotechnology DPT Series Vaccine Product and Services
Table 114. Walvax Biotechnology DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Walvax Biotechnology Recent Developments/Updates
Table 116. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 117. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 118. Serum Institute of India Major Business
Table 119. Serum Institute of India DPT Series Vaccine Product and Services
Table 120. Serum Institute of India DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Serum Institute of India Recent Developments/Updates
Table 122. Serum Institute of India Competitive Strengths & Weaknesses
Table 123. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 124. Bharat Biotech Major Business
Table 125. Bharat Biotech DPT Series Vaccine Product and Services
Table 126. Bharat Biotech DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Bharat Biotech Recent Developments/Updates
Table 128. Bharat Biotech Competitive Strengths & Weaknesses
Table 129. Boryung Biopharama Basic Information, Manufacturing Base and Competitors
Table 130. Boryung Biopharama Major Business
Table 131. Boryung Biopharama DPT Series Vaccine Product and Services
Table 132. Boryung Biopharama DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Boryung Biopharama Recent Developments/Updates
Table 134. Boryung Biopharama Competitive Strengths & Weaknesses
Table 135. Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 136. Tanabe Pharma Major Business
Table 137. Tanabe Pharma DPT Series Vaccine Product and Services
Table 138. Tanabe Pharma DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Tanabe Pharma Recent Developments/Updates
Table 140. Tanabe Pharma Competitive Strengths & Weaknesses
Table 141. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 142. KM Biologics Major Business
Table 143. KM Biologics DPT Series Vaccine Product and Services
Table 144. KM Biologics DPT Series Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. KM Biologics Recent Developments/Updates
Table 146. KM Biologics Competitive Strengths & Weaknesses
Table 147. Global Key Players of DPT Series Vaccine Upstream (Raw Materials)
Table 148. Global DPT Series Vaccine Typical Customers
Table 149. DPT Series Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. DPT Series Vaccine Picture
Figure 2. World DPT Series Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World DPT Series Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World DPT Series Vaccine Production (2021-2032) & (K Dose)
Figure 5. World DPT Series Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World DPT Series Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World DPT Series Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America DPT Series Vaccine Production (2021-2032) & (K Dose)
Figure 9. Europe DPT Series Vaccine Production (2021-2032) & (K Dose)
Figure 10. China DPT Series Vaccine Production (2021-2032) & (K Dose)
Figure 11. Japan DPT Series Vaccine Production (2021-2032) & (K Dose)
Figure 12. DPT Series Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 15. World DPT Series Vaccine Consumption Market Share by Region (2021-2032)
Figure 16. United States DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 17. China DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. Europe DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. Japan DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. South Korea DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 22. India DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of DPT Series Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for DPT Series Vaccine Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for DPT Series Vaccine Markets in 2025
Figure 26. United States VS China: DPT Series Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: DPT Series Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: DPT Series Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers DPT Series Vaccine Production Market Share 2025
Figure 30. China Based Manufacturers DPT Series Vaccine Production Market Share 2025
Figure 31. Rest of World Based Manufacturers DPT Series Vaccine Production Market Share 2025
Figure 32. World DPT Series Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World DPT Series Vaccine Production Value Market Share by Type in 2025
Figure 34. Whole-cell DPT Vaccine
Figure 35. Acellular DPT Vaccine
Figure 36. World DPT Series Vaccine Production Market Share by Type (2021-2032)
Figure 37. World DPT Series Vaccine Production Value Market Share by Type (2021-2032)
Figure 38. World DPT Series Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. World DPT Series Vaccine Production Value by Combination, (USD Million), 2021 & 2025 & 2032
Figure 40. World DPT Series Vaccine Production Value Market Share by Combination in 2025
Figure 41. Trivalent Vaccine
Figure 42. Quadrivalent Vaccine
Figure 43. Pentavalent Vaccine
Figure 44. Others
Figure 45. World DPT Series Vaccine Production Market Share by Combination (2021-2032)
Figure 46. World DPT Series Vaccine Production Value Market Share by Combination (2021-2032)
Figure 47. World DPT Series Vaccine Average Price by Combination (2021-2032) & (US$/Dose)
Figure 48. World DPT Series Vaccine Production Value by Effect, (USD Million), 2021 & 2025 & 2032
Figure 49. World DPT Series Vaccine Production Value Market Share by Effect in 2025
Figure 50. Basic Vaccines
Figure 51. Booster Vaccines
Figure 52. World DPT Series Vaccine Production Market Share by Effect (2021-2032)
Figure 53. World DPT Series Vaccine Production Value Market Share by Effect (2021-2032)
Figure 54. World DPT Series Vaccine Average Price by Effect (2021-2032) & (US$/Dose)
Figure 55. World DPT Series Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World DPT Series Vaccine Production Value Market Share by Application in 2025
Figure 57. Public
Figure 58. Private
Figure 59. World DPT Series Vaccine Production Market Share by Application (2021-2032)
Figure 60. World DPT Series Vaccine Production Value Market Share by Application (2021-2032)
Figure 61. World DPT Series Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 62. DPT Series Vaccine Industry Chain
Figure 63. DPT Series Vaccine Procurement Model
Figure 64. DPT Series Vaccine Sales Model
Figure 65. DPT Series Vaccine Sales Channels, Direct Sales, and Distribution
Figure 66. Methodology
Figure 67. Research Process and Data Source
Figure 1. DPT Series Vaccine Picture
Figure 2. World DPT Series Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World DPT Series Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World DPT Series Vaccine Production (2021-2032) & (K Dose)
Figure 5. World DPT Series Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World DPT Series Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World DPT Series Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America DPT Series Vaccine Production (2021-2032) & (K Dose)
Figure 9. Europe DPT Series Vaccine Production (2021-2032) & (K Dose)
Figure 10. China DPT Series Vaccine Production (2021-2032) & (K Dose)
Figure 11. Japan DPT Series Vaccine Production (2021-2032) & (K Dose)
Figure 12. DPT Series Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 15. World DPT Series Vaccine Consumption Market Share by Region (2021-2032)
Figure 16. United States DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 17. China DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. Europe DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. Japan DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. South Korea DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 22. India DPT Series Vaccine Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of DPT Series Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for DPT Series Vaccine Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for DPT Series Vaccine Markets in 2025
Figure 26. United States VS China: DPT Series Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: DPT Series Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: DPT Series Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers DPT Series Vaccine Production Market Share 2025
Figure 30. China Based Manufacturers DPT Series Vaccine Production Market Share 2025
Figure 31. Rest of World Based Manufacturers DPT Series Vaccine Production Market Share 2025
Figure 32. World DPT Series Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World DPT Series Vaccine Production Value Market Share by Type in 2025
Figure 34. Whole-cell DPT Vaccine
Figure 35. Acellular DPT Vaccine
Figure 36. World DPT Series Vaccine Production Market Share by Type (2021-2032)
Figure 37. World DPT Series Vaccine Production Value Market Share by Type (2021-2032)
Figure 38. World DPT Series Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. World DPT Series Vaccine Production Value by Combination, (USD Million), 2021 & 2025 & 2032
Figure 40. World DPT Series Vaccine Production Value Market Share by Combination in 2025
Figure 41. Trivalent Vaccine
Figure 42. Quadrivalent Vaccine
Figure 43. Pentavalent Vaccine
Figure 44. Others
Figure 45. World DPT Series Vaccine Production Market Share by Combination (2021-2032)
Figure 46. World DPT Series Vaccine Production Value Market Share by Combination (2021-2032)
Figure 47. World DPT Series Vaccine Average Price by Combination (2021-2032) & (US$/Dose)
Figure 48. World DPT Series Vaccine Production Value by Effect, (USD Million), 2021 & 2025 & 2032
Figure 49. World DPT Series Vaccine Production Value Market Share by Effect in 2025
Figure 50. Basic Vaccines
Figure 51. Booster Vaccines
Figure 52. World DPT Series Vaccine Production Market Share by Effect (2021-2032)
Figure 53. World DPT Series Vaccine Production Value Market Share by Effect (2021-2032)
Figure 54. World DPT Series Vaccine Average Price by Effect (2021-2032) & (US$/Dose)
Figure 55. World DPT Series Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World DPT Series Vaccine Production Value Market Share by Application in 2025
Figure 57. Public
Figure 58. Private
Figure 59. World DPT Series Vaccine Production Market Share by Application (2021-2032)
Figure 60. World DPT Series Vaccine Production Value Market Share by Application (2021-2032)
Figure 61. World DPT Series Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 62. DPT Series Vaccine Industry Chain
Figure 63. DPT Series Vaccine Procurement Model
Figure 64. DPT Series Vaccine Sales Model
Figure 65. DPT Series Vaccine Sales Channels, Direct Sales, and Distribution
Figure 66. Methodology
Figure 67. Research Process and Data Source
